Ezatiostat (TER199 free base; TLK199) is a tripeptide analog of glutathione and is a selective and orally active glutathione S-transferase P1-1 (GSTP1) inhibitor. Ezatiostat leads to JNK activation by inhibiting GSTP1. Ezatiostat stimulates both lymphocyte production and bone marrow progenitor proliferation. Ezatiostat has the potential for myelodysplastic syndrome (MDS) treatment.
CAT No: HB00099
CAS No:168682-53-9
Synonyms/Alias:Ezatiostat;168682-53-9;Ezatiostat [INN];Terrapin 199;TLK-199;UNII-057D10I8S8;057D10I8S8;TLK199;Glycine, L-g-glutamyl-S-(phenylmethyl)-L-cysteinyl-2-phenyl-,1,3-diethyl ester, (2R)-;ethyl (2S)-2-amino-5-[[(2R)-3-benzylsulfanyl-1-[[(1R)-2-ethoxy-2-oxo-1-phenylethyl]amino]-1-oxopropan-2-yl]amino]-5-oxopentanoate;DTXSID40168592;gamma-Glutamyl-S-(benzyl)-cysteinyl-R(-)-phenylglycine diethyl ester;ezatiotsat;TER 199;TLK 199;ethyl (2S)-2-amino-4-{[(1R)-2-(benzylsulfanyl)-1-{[(1R)-2-ethoxy-2-oxo-1-phenylethyl]carbamoyl}ethyl]carbamoyl}butanoate;Glycine, L-gamma-glutamyl-S-(phenylmethyl)-L-cysteinyl-2-phenyl-, diethyl ester, (2R)-;Glycine, N-(N-L-gamma-glutamyl-S-(phenylmethyl)-L-cysteinyl)-D-2-phenyl-, diethyl ester;TLK 117;ETHYL (2R)-((4S)-4-AMINO-5-ETHOXY-5-OXOPENTANOYL)-S-BENZYL-L-CYSTEINYL-2-PHENYLGLYCINATE;Ethyl N5-((R)-3-(benzylthio)-1-(((R)-2-ethoxy-2-oxo-1-phenylethyl)amino)-1-oxopropan-2-yl)-L-glutaminate;GLYCINE, L-.GAMMA.-GLUTAMYL-S-(PHENYLMETHYL)-L-CYSTEINYL-2-PHENYL-, DIETHYL ESTER, (2R)-;T.199;ezatiostatum;ethyl (2S)-2-amino-4-(((1R)-2-(benzylsulfanyl)-1-(((1R)-2-ethoxy-2-oxo-1-phenylethyl)carbamoyl)ethyl)carbamoyl)butanoate;gamma-glutamyl-S-(benzyl)cysteinyl-phenylglycine diethyl ester;MFCD27982957;SCHEMBL420400;CHEMBL2110585;DTXCID8091083;EX-A345;HY-13634A;NSC758484;AKOS005266721;CS-1713;DB05460;NSC-758484;NCGC00263221-01;NCGC00263221-05;AS-74082;DA-63345;NS00072776;BRD-K98963219-001-01-2;Q27095680;(2R)-L-gamma-Glutamyl-S-(phenylmethyl)-L-cysteinyl-2-phenyl-glycine Diethyl Ester; N-[N-L-gamma-Glutamyl-S-(phenylmethyl)-L-cysteinyl]-D-2-phenyl-glycine Diethyl Ester; Ter 199; Terrapin 199;
Ezatiostat, also known as TLK199, is a synthetic tripeptide analog designed to modulate key cellular pathways involved in hematopoiesis and immune regulation. Characterized by its unique structure that mimics glutathione analogs, Ezatiostat acts as an inhibitor of glutathione S-transferase P1-1 (GSTP1-1), a critical enzyme implicated in cellular detoxification and signal transduction. Its selective mechanism of action enables researchers to probe the intricate balance between oxidative stress responses and cellular proliferation. Due to these properties, Ezatiostat has garnered significant interest in both academic and industrial research settings, particularly for its utility in dissecting redox biology, cell differentiation, and immune signaling pathways.
Hematopoietic Research: Ezatiostat is widely utilized in studies focused on hematopoietic stem and progenitor cell biology. By inhibiting GSTP1-1, it modulates intracellular signaling cascades that influence the proliferation and differentiation of myeloid and erythroid lineages. Researchers employ this compound to investigate the molecular underpinnings of bone marrow microenvironment dynamics and to develop strategies for enhancing hematopoietic recovery in various experimental models. Its application in these studies provides valuable insights into the regulation of blood cell formation and the potential for manipulating these processes for research purposes.
Redox Biology Investigations: TLK199 serves as a powerful tool in the exploration of oxidative stress and antioxidant defense mechanisms. By targeting GSTP1-1, it allows scientists to dissect the roles of glutathione-dependent enzymes in maintaining cellular redox homeostasis. This enables the elucidation of how alterations in redox balance affect cell survival, apoptosis, and metabolic adaptation under physiological and stress conditions. The compound's ability to modulate glutathione metabolism makes it indispensable for studies aiming to understand the interplay between cellular detoxification systems and disease-related oxidative damage.
Signal Transduction Studies: The use of Ezatiostat extends to the analysis of signal transduction pathways, particularly those involving c-Jun N-terminal kinase (JNK) and related kinases. By interfering with GSTP1-1, which acts as a negative regulator of JNK, the compound facilitates the activation of stress-activated protein kinase pathways. This property is exploited in laboratory experiments to delineate the downstream effects of JNK activation on gene expression, cell cycle progression, and programmed cell death. As such, it provides a valuable approach for mapping intricate signaling networks that control cell fate decisions.
Immunological Research: Researchers leverage TLK199 to investigate immune cell differentiation and function. Its impact on GSTP1-1 activity allows for the modulation of cytokine production, immune cell proliferation, and the regulation of inflammatory responses. Studies utilizing this compound reveal important connections between detoxification enzymes and immune system regulation, offering a deeper understanding of how redox-sensitive pathways influence immune homeostasis and response to external stimuli. The insights gained from these investigations contribute to the broader knowledge of immune modulation and the development of novel immunological research models.
Cancer Biology Exploration: Ezatiostat is frequently employed in cancer biology research to study the role of GSTP1-1 in tumor cell proliferation, survival, and resistance to oxidative stress. By inhibiting this enzyme, researchers can assess the contribution of glutathione metabolism to oncogenic signaling, tumor progression, and cellular resilience in the face of chemotherapeutic agents. The compound is particularly useful in cell-based assays designed to evaluate the impact of redox modulation on cancer cell viability, apoptosis, and adaptation to hostile microenvironments. These applications facilitate the discovery of new molecular targets and pathways relevant to cancer research.
In summary, Ezatiostat stands out as a versatile research compound with broad applications across hematopoietic studies, redox biology, signal transduction, immunology, and cancer biology. Its unique ability to selectively inhibit GSTP1-1 provides researchers with a robust tool for dissecting complex cellular mechanisms, advancing scientific understanding in multiple fields of biomedical research, and enabling the development of innovative experimental models.
2. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
4. Myotropic activity of allatostatins in tenebrionid beetles
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.